|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.12 HKD | -2.26% |
|
+2.02% | -6.84% |
| 03-11 | Abbisko Drug Receives Rare Pediatric Designation in U.S. | MT |
| 03-11 | Abbisko Cayman says US FDA grants rare pediatric disease designation for FGFR2/3 inhibitor ABSK061 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.04B | - | ||||
| 42.98B | |||||
| 39.24B | |||||
| 30.07B | - | ||||
| 21.88B | - | ||||
| 18.25B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition